Brentuximab vedotin
Brentuximab vedotin (SGN-35) is a CD30-targeting antibody-active molecule conjugate (ADC) that combines a CD30 monoclonal antibody with the microtubule disrupting agent monomethylauristatin E for the study of lymphoma.
Product Specifications
CAS Number
914088-09-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 145.58 kDa.
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antibody-Drug Conjugates (ADCs)
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog